Quercetin inhibits the migration and proliferation of astrocytes in wound healing

NeuroReport

Volumn 26, Issue 7, 2015, Pages 387-393

  Yuan, Zhaohu ^a   Yao, Fang ^b   Hu, Ziyou ^b   Sun, Shumei ^b   Wu, Bingyi ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

astrocytes; migration; proliferation; quercetin

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; FAK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN; QUERCETIN; UNCLASSIFIED DRUG; VANADIC ACID; 1,3 BUTADIENE DERIVATIVE; ANTIOXIDANT; ENZYME INHIBITOR; FOCAL ADHESION KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; NITRILE; PTK2 PROTEIN, RAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL CONTACT; CELL CYCLE; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SCAR FORMATION; SIGNAL TRANSDUCTION; WOUND CLOSURE; WOUND HEALING; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN CORTEX; CELL CULTURE; CELL MOTION; CELL SURVIVAL; CICATRIX; DRUG EFFECTS; METABOLISM; NEWBORN; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; ASTROCYTES; BUTADIENES; CELL CYCLE; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CICATRIX; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESION KINASE 1; NITRILES; PHOSPHORYLATION; QUERCETIN; RATS, SPRAGUE-DAWLEY; VANADATES; WOUND HEALING;

EID: 84928333036     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0000000000000352     Document Type: Article

References (23)

1. Nimmerjahn A. Astrocytes going live: advances and challenges. J Physiol 2009; 587 (Pt 8):1639-1647.
2. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009; 32:638-647.
3. Fawcett JW, Asher RA. The glial scar and central nervous system repair. Brain Res Bull 1999; 49:377-391.
4. Reier PJ, Houle JD. The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair. Adv Neurol 1988; 47:87-138.
5. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007; 8:57-69.
6. Luo Y, Raper JA. Inhibitory factors controlling growth cone motility and guidance. Curr Opin Neurobiol 1994; 4:648-654.
7. Pawlikowska-Pawlega B, Gruszecki WI, Misiak LE, Gawron A. The study of the quercetin action on human erythrocyte membranes. Biochem Pharmacol 2003; 66:605-612.
8. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002; 22:19-34.
9. Soliman KF, Mazzio EA. In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc Soc Exp Biol Med 1998; 218:390-397.
10. Conklin DR, Tan KH, Aschner M. Dimethyl sulfoxide, but not acidosis-induced metallothionein mRNA expression in neonatal rat primary astrocyte cultures is inhibited by the bioflavonoid, quercetin. Brain Res 1998; 794:304-308.
11. Nones J, Spohr TC, Gomes FC. Effects of the flavonoid hesperidin in cerebral cortical progenitors in vitro: indirect action through astrocytes. Int J Dev Neurosci 2012; 30:303-313.
12. Hwang IK, Lee CH, Yoo KY, Choi JH, Park OK, Lim SS, et al. Neuroprotective effects of onion extract and quercetin against ischemic neuronal damage in the gerbil hippocampus. J Med Food 2009; 12:990-995.
13. Wu BY, Yu AC. Quercetin inhibits c-fos, heat shock protein, and glial fibrillary acidic protein expression in injured astrocytes. J Neurosci Res 2000; 62:730-736.
14. Shan BE, Wang MX, Li RQ. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest 2009; 27:604-612.
15. Ye B, Aponte M, Dai Y, Li L, Ho MC, Vitonis A, et al. Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence. Cancer Lett 2007; 251:43-52.
16. Vauzour D, Vafeiadou K, Rice-Evans C, Williams RJ, Spencer JP. Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the antiapoptotic effects of flavanones in cortical neurons. J Neurochem 2007; 103:1355-1367.
17. Spencer JP, Rice-Evans C, Williams RJ. Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 2003; 278:34783-34793.
18. Lichtenstein MP, Carriba P, Baltrons MA, Wojciak-Stothard B, Peterson JR, García A, Galea E. Secretase-independent and RhoGTPase/PAK/ERKdependent regulation of cytoskeleton dynamics in astrocytes by NSAIDs and derivatives. J Alzheimers Dis 2010; 22:1135-1155.
19. Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, et al. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 2008; 28:7231-7243.
20. Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 2006; 545:51-64.
21. Wang P, Zhang K, Zhang Q, Mei J, Chen CJ, Feng ZZ, Yu DH. Effects of quercetin on the apoptosis of the human gastric carcinoma cells. Toxicol In Vitro 2012; 26:221-228.
22. Zamin LL, Filippi-Chiela EC, Dillenburg-Pilla P, Horn F, Salbego C, Lenz G. Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. Cancer Sci 2009; 100:1655-1662.
23. Teranishi S, Kimura K, Nishida T. Role of formation of an ERK-FAK-paxillin complex in migration of human corneal epithelial cells during wound closure in vitro. Invest Ophthalmol Vis Sci 2009; 50:5646-5652.